Expert Insight: 5 top webinars coming up this week
Explore hot topics from 3D X-ray microscopy and
in vitro diagnostics to gas chromatography and synthetic guide RNAs
01 Mar 2021
SelectScience
® hosts dozens of informative and insightful free webinars for scientists every month, featuring world-class speakers at the very forefront of their respective fields. In our regular weekly feature, we ll be highlighting the exciting and informative events you won t want to miss over the next week or so, as well as some of our top on-demand webinars. Register now to save your spot and hear from experts as they discuss the latest research and technologies in their fields, from
Expert Insight: Don t miss out on these 6 new expert webinars
Explore topics from
22 Feb 2021
SelectScience
® hosts dozens of informative and insightful free webinars for scientists every month, featuring world-class speakers at the very forefront of their respective fields. In our regular weekly feature, we ll be highlighting the exciting and informative events you won t want to miss over the next week or so, as well as some of our top on-demand webinars. Register now to save your spot and hear from experts as they discuss the latest research and technologies in their fields, from
in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development.
Posted February 11th, 2021 for kdm communications
Tecan has become one of the first companies to meet the requirements of the European Union’s In Vitro Diagnostic Regulation (IVDR) 2017/746 (Annex IX, Chapter I and III), successfully completing certification of its IBL International DHEA Saliva ELISA diagnostic assay kit through BSI Notified Body 2797.
Mannedorf, Switzerland, February 11, 2021 - /PressReleasePoint/ - The valuable insights gained from this process will now be applied to the registration of Tecan’s complete portfolio of specialty IVD products – as well as to help its OEM partners ensure they are ‘IVDR ready’ – ahead of the May 2022 transition deadline.
The new IVDR is intended to increase the safety of all IVD products, including all innovations developed over the past decades. It represents a major regulatory overhaul, requiring reclassification and certification of all EU-registered IVD assays and devices. Introduced in 2017, it extends the
Closing The Loop On Risk Management With ISO 14971:2019
This is the second in a series of articles on the changes in the medical device risk management standard ISO 14971 that were released in December of 2019 and supported by guidance in the ISO TR 24971:2020 technical report or guidance on the medical device risk management standard. The standard and the technical report were reorganized and clarifications of the concepts of medical device risk management were included in the two documents. Few changes in the process resulted, but this article covers the major change in the process: production and post-production information covered in Clause 10 of the standard.